Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.

Benítez-Cano A, de Antonio-Cuscó M, Luque S, Sorlí L, Carazo J, Ramos I, Bermejo S, Campillo N, Horcajada JP, Samsó E, Grau S.

J Antimicrob Chemother. 2019 Sep 8. pii: dkz356. doi: 10.1093/jac/dkz356. [Epub ahead of print]

PMID:
31495877
2.

Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.

Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S.

Clin Microbiol Rev. 2019 Aug 28;32(4). pii: e00031-19. doi: 10.1128/CMR.00031-19. Print 2019 Sep 18. Review.

PMID:
31462403
3.

Effects of the extracorporeal membrane oxygenation circuit on plasma levels of ceftolozane.

Argudo E, Riera J, Luque S, Los-Arcos I, López-Meseguer M, Sandiumenge A, Nuvials X, Grau S, Ferrer R.

Perfusion. 2019 Aug 7:267659119864813. doi: 10.1177/0267659119864813. [Epub ahead of print]

PMID:
31387460
4.

Recovery of fenbendazole efficacy on resistant Haemonchus contortus by management of parasite refugia and population replacement.

Muchiut SM, Fernández AS, Lloberas M, Steffan PE, Luque SE, Cardozo PA, Bernat GA, Riva E, Fiel CA.

Vet Parasitol. 2019 Jul;271:31-37. doi: 10.1016/j.vetpar.2019.06.003. Epub 2019 Jun 6.

PMID:
31303200
5.

Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical.

Sorlí L, Luque S, Li J, Campillo N, Danés M, Montero M, Segura C, Grau S, Horcajada JP.

J Infect. 2019 Sep;79(3):253-261. doi: 10.1016/j.jinf.2019.06.011. Epub 2019 Jun 29.

PMID:
31265867
6.

Linezolid dosing in patients with liver cirrhosis: Standard dosing risks toxicity.

Luque S, Muñoz-Bermudez R, Echeverría-Esnal D, Sorli L, Campillo N, Martínez-Casanova J, González-Colominas E, Álvarez-Lerma F, Horcajada JP, Grau S, Roberts JA.

Ther Drug Monit. 2019 Jun 26. doi: 10.1097/FTD.0000000000000665. [Epub ahead of print]

PMID:
31259884
7.

Pharmacologic interaction between oxfendazole and triclabendazole: In vitro biotransformation and systemic exposure in sheep.

Viviani P, Lifschitz AL, Luque SE, Lloberas MM, Maté ML, Cardozo PA, Lanusse CE, Virkel GL.

Exp Parasitol. 2019 Sep;204:107718. doi: 10.1016/j.exppara.2019.107718. Epub 2019 Jun 12.

PMID:
31201779
8.

Nature's contributions to people in mountains: A review.

Martín-López B, Leister I, Lorenzo Cruz P, Palomo I, Grêt-Regamey A, Harrison PA, Lavorel S, Locatelli B, Luque S, Walz A.

PLoS One. 2019 Jun 11;14(6):e0217847. doi: 10.1371/journal.pone.0217847. eCollection 2019.

9.

Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.

Montero MM, Domene Ochoa S, López-Causapé C, VanScoy B, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Segura C, Pomar V, Rivera A, Grau S, Ambrose PG, Oliver A, Horcajada JP.

J Glob Antimicrob Resist. 2019 May 30;18:37-44. doi: 10.1016/j.jgar.2019.04.012. [Epub ahead of print]

PMID:
31154007
10.

Population Pharmacokinetics of Anidulafungin in Critically Ill Patients.

Luque S, Hope W, Campillo N, Muñoz-Bermúdez R, Sorli L, Barceló-Vidal J, González-Colominas E, Alvarez-Lerma F, Masclans JR, Montero M, Horcajada JP, Grau S.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00378-19. doi: 10.1128/AAC.00378-19. Print 2019 Jul.

PMID:
31061150
11.

Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?

Sorli L, Luque S, Li J, Rodríguez E, Campillo N, Fernandez X, Soldado J, Domingo I, Montero M, Grau S, Horcajada JP.

Molecules. 2019 Feb 1;24(3). pii: E530. doi: 10.3390/molecules24030530.

12.

Serum albumin is a strong predictor of sepsis outcome in elderly patients.

Arnau-Barrés I, Güerri-Fernández R, Luque S, Sorli L, Vázquez O, Miralles R.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):743-746. doi: 10.1007/s10096-019-03478-2. Epub 2019 Jan 24.

PMID:
30680575
13.

Biogeographical network analysis of plant species distribution in the Mediterranean region.

Lenormand M, Papuga G, Argagnon O, Soubeyrand M, De Barros G, Alleaume S, Luque S.

Ecol Evol. 2018 Dec 21;9(1):237-250. doi: 10.1002/ece3.4718. eCollection 2019 Jan.

14.

Pharmacokinetics of Micafungin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis With High Cutoff Membranes.

Tenorio-Cañamás T, Grau S, Luque S, Fortún J, Liaño F, Roberts JA.

Ther Drug Monit. 2019 Jun;41(3):376-382. doi: 10.1097/FTD.0000000000000595.

PMID:
30633087
15.

Multiscale socio-ecological networks in the age of information.

Lenormand M, Luque S, Langemeyer J, Tenerelli P, Zulian G, Aalders I, Chivulescu S, Clemente P, Dick J, van Dijk J, van Eupen M, Giuca RC, Kopperoinen L, Lellei-Kovács E, Leone M, Lieskovský J, Schirpke U, Smith AC, Tappeiner U, Woods H.

PLoS One. 2018 Nov 1;13(11):e0206672. doi: 10.1371/journal.pone.0206672. eCollection 2018.

16.

CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy.

Jarque M, Melilli E, Crespo E, Manonelles A, Montero N, Torras J, Cruzado JM, Luque S, Gil-Vernet S, Grinyó JM, Bestard O.

Transplantation. 2018 Nov;102(11):e472-e480. doi: 10.1097/TP.0000000000002421.

PMID:
30130330
17.

Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.

Luque S, Lúcia M, Melilli E, Lefaucheur C, Crespo M, Loupy A, Bernal-Casas D, Gomà M, Jarque M, Crespo E, Montero N, Manonelles A, Cruzado JM, Gil-Vernet S, Grinyó JM, Bestard O.

Am J Transplant. 2019 Feb;19(2):368-380. doi: 10.1111/ajt.15055. Epub 2018 Sep 17.

PMID:
30085394
18.

A multicolour HLA-specific B-cell FluoroSpot assay to functionally track circulating HLA-specific memory B cells.

Luque S, Lúcia M, Crespo E, Jarque M, Grinyó JM, Bestard O.

J Immunol Methods. 2018 Nov;462:23-33. doi: 10.1016/j.jim.2018.07.011. Epub 2018 Jul 31.

PMID:
30075182
19.

Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.

Gandolfini I, Crespo E, Baweja M, Jarque M, Donadei C, Luque S, Montero N, Allesina A, Perin L, Maggiore U, Cravedi P, Bestard O.

PLoS One. 2018 Jul 30;13(7):e0200696. doi: 10.1371/journal.pone.0200696. eCollection 2018.

20.

Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.

Maseda E, Grau S, Luque S, Castillo-Mafla MP, Suárez-de-la-Rica A, Montero-Feijoo A, Salgado P, Gimenez MJ, García-Bernedo CA, Gilsanz F, Roberts JA.

Crit Care. 2018 Apr 15;22(1):94. doi: 10.1186/s13054-018-2019-8.

21.

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis.

Martínez-Casanova J, Carballo N, Luque S, Sorli L, Grau S.

Infect Drug Resist. 2018 Mar 5;11:317-321. doi: 10.2147/IDR.S154457. eCollection 2018.

22.

Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit.

Lobo M, López-Tarruella S, Luque S, Lizarraga S, Flores-Sánchez C, Bueno O, Solera J, Jerez Y, Del Val RG, Palomero MI, Cebollero M, Echavarría I, Torres G, Martín M, Márquez-Rodas I.

J Genet Couns. 2018 Aug;27(4):854-862. doi: 10.1007/s10897-017-0187-3. Epub 2017 Dec 15.

PMID:
29247312
23.

Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.

Molas E, Luque S, Retamero A, Echeverría-Esnal D, Guelar A, Montero M, Guerri R, Sorli L, Lerma E, Villar J, Knobel H.

HIV Clin Trials. 2018 Feb;19(1):1-7. doi: 10.1080/15284336.2017.1404690. Epub 2017 Nov 28.

PMID:
29179644
24.

Refinement of humoral immune monitoring in kidney transplantation: the role of "hidden" alloreactive memory B cells.

Luque S, Lúcia M, Bestard O.

Transpl Int. 2017 Oct;30(10):955-968. doi: 10.1111/tri.13014. Review.

25.

IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.

Long KB, Tooker G, Tooker E, Luque SL, Lee JW, Pan X, Beatty GL.

Mol Cancer Ther. 2017 Sep;16(9):1898-1908. doi: 10.1158/1535-7163.MCT-16-0899. Epub 2017 Jun 13.

26.

Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.

Luque S, Escaño C, Sorli L, Li J, Campillo N, Horcajada JP, Salas E, Grau S.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e02595-16. doi: 10.1128/AAC.02595-16. Print 2017 Aug.

27.

Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients.

Crespo E, Fernandez L, Lúcia M, Melilli E, Lauzurica R, Penin RM, Quer A, Luque S, Quero M, Manonelles A, Torras J, Cruzado JM, Cañas L, Grinyó JM, Bestard O.

Transplantation. 2017 Sep;101(9):2102-2110. doi: 10.1097/TP.0000000000001759.

PMID:
28403126
28.

Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.

Crespo E, Cravedi P, Martorell J, Luque S, Melilli E, Cruzado JM, Jarque M, Meneghini M, Manonelles A, Donadei C, Lloberas N, Gomà M, Grinyó JM, Heeger P, Bestard O.

Kidney Int. 2017 Jul;92(1):201-213. doi: 10.1016/j.kint.2016.12.024. Epub 2017 Mar 6.

29.

Community-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in critically-ill patients: systematic review.

Carballo N, De Antonio-Cuscó M, Echeverría-Esnal D, Luque S, Salas E, Grau S.

Farm Hosp. 2017 Mar 1;41(2):187-203. doi: 10.7399/fh.2017.41.2.10591. Review.

30.

Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.

Horcajada JP, Sorlí L, Luque S, Benito N, Segura C, Campillo N, Montero M, Esteve E, Mirelis B, Pomar V, Cuquet J, Martí C, Garro P, Grau S.

Int J Antimicrob Agents. 2016 Dec;48(6):725-727. doi: 10.1016/j.ijantimicag.2016.08.020. Epub 2016 Oct 7.

PMID:
28128096
31.

Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.

Sorlí L, Luque S, Segura C, Campillo N, Montero M, Esteve E, Herrera S, Benito N, Alvarez-Lerma F, Grau S, Horcajada JP.

BMC Infect Dis. 2017 Jan 5;17(1):11. doi: 10.1186/s12879-016-2117-7.

32.

Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital.

Márquez-Rodas I, Lobo M, Flores-Sanchez C, Sanz M, Luque S, Lizarraga S, González-Asanza C, Pajares JA, Peligros MI, Bueno O, Mata C, Lopez C, López-Tarruella S, Jerez Y, Muñoz-Martin A, Blanco M, Die-Trill M, Justel JP, Solera J, Martin M.

Oncology. 2017;92(2):68-74. doi: 10.1159/000452280. Epub 2016 Nov 18.

PMID:
27855387
33.

Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.

García-de-Lorenzo A, Luque S, Grau S, Agrifoglio A, Cachafeiro L, Herrero E, Asensio MJ, Sánchez SM, Roberts JA.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5914-21. doi: 10.1128/AAC.00727-16. Print 2016 Oct.

34.

Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.

Grau S, Luque S, Echeverría-Esnal D, Sorlí L, Campillo N, Montero M, Álvarez Lerma F, Plasencia V, Horcajada JP.

Int J Antimicrob Agents. 2016 Aug;48(2):212-4. doi: 10.1016/j.ijantimicag.2016.05.010. Epub 2016 Jul 5.

PMID:
27424599
35.

Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.

Crespo E, Roedder S, Sigdel T, Hsieh SC, Luque S, Cruzado JM, Tran TQ, Grinyó JM, Sarwal MM, Bestard O.

Transplantation. 2017 Jun;101(6):1400-1409. doi: 10.1097/TP.0000000000001287.

PMID:
27362314
36.

Successful treatment of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus pneumonia with high doses of linezolid administered in continuous infusion.

Álvarez-Lerma F, Muñoz-Bermúdez R, Samper-Sánchez MA, Gracia Arnilla MP, Grau S, Luque S.

Med Intensiva. 2017 Jan - Feb;41(1):56-59. doi: 10.1016/j.medin.2016.04.006. Epub 2016 Jun 4. English, Spanish. No abstract available.

37.

What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?

Alobaid AS, Brinkmann A, Frey OR, Roehr AC, Luque S, Grau S, Wong G, Abdul-Aziz MH, Roberts MS, Lipman J, Roberts JA.

J Antimicrob Chemother. 2016 Mar;71(3):696-702. doi: 10.1093/jac/dkv412. Epub 2015 Dec 24.

PMID:
26702922
38.

Spatial Bayesian belief networks as a planning decision tool for mapping ecosystem services trade-offs on forested landscapes.

Gonzalez-Redin J, Luque S, Poggio L, Smith R, Gimona A.

Environ Res. 2016 Jan;144(Pt B):15-26. doi: 10.1016/j.envres.2015.11.009. Epub 2015 Nov 18.

PMID:
26597639
39.

Low Non-structured Antiretroviral Therapy Interruptions in HIV-Infected Persons Who Inject Drugs Receiving Multidisciplinary Comprehensive HIV Care at an Outpatient Drug Abuse Treatment Center.

Vallecillo G, Mojal S, Roquer A, Samos P, Luque S, Martinez D, Martires PK, Torrens M.

AIDS Behav. 2016 May;20(5):1068-75. doi: 10.1007/s10461-015-1211-y.

PMID:
26427376
40.

Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.

Grau S, Luque S, Campillo N, Samsó E, Rodríguez U, García-Bernedo CA, Salas E, Sharma R, Hope WW, Roberts JA.

J Antimicrob Chemother. 2015 Oct;70(10):2854-61. doi: 10.1093/jac/dkv173. Epub 2015 Jul 14.

PMID:
26180134
41.

Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.

Lúcia M, Luque S, Crespo E, Melilli E, Cruzado JM, Martorell J, Jarque M, Gil-Vernet S, Manonelles A, Grinyó JM, Bestard O.

Kidney Int. 2015 Oct;88(4):874-87. doi: 10.1038/ki.2015.205. Epub 2015 Jul 15.

PMID:
26176829
42.

Comment on: Pharmacokinetics of high dosage of linezolid in two morbidly obese patients.

Lopez-Garcia B, Luque S, Maseda E, Grau S.

J Antimicrob Chemother. 2015 Nov;70(11):3168. doi: 10.1093/jac/dkv209. Epub 2015 Jul 13. No abstract available.

PMID:
26169559
43.

Pharmacokinetics and preliminary safety of high dose linezolid for the treatment of Gram-positive bacterial infections.

Lopez-Garcia B, Luque S, Roberts JA, Grau S.

J Infect. 2015 Nov;71(5):604-7. doi: 10.1016/j.jinf.2015.06.007. Epub 2015 Jun 19. No abstract available.

PMID:
26099449
44.

Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.

Beatty GL, Winograd R, Evans RA, Long KB, Luque SL, Lee JW, Clendenin C, Gladney WL, Knoblock DM, Guirnalda PD, Vonderheide RH.

Gastroenterology. 2015 Jul;149(1):201-10. doi: 10.1053/j.gastro.2015.04.010. Epub 2015 Apr 14.

45.

Pharmacokinetics of micafungin in patients with pre-existing liver dysfunction: A safe option for treating invasive fungal infections.

Luque S, Campillo N, Álvarez-Lerma F, Ferrández O, Horcajada JP, Grau S.

Enferm Infecc Microbiol Clin. 2016 Dec;34(10):652-654. doi: 10.1016/j.eimc.2015.02.021. Epub 2015 Apr 14.

PMID:
25882063
46.

Antifungal therapeutic drug monitoring: when, how, and why.

Grau S, Luque S.

Enferm Infecc Microbiol Clin. 2015 May;33(5):295-7. doi: 10.1016/j.eimc.2015.03.005. Epub 2015 Apr 8. No abstract available.

PMID:
25861923
47.

Comparative pharmacokinetic and pharmacodynamic response of single and double intraruminal doses of ivermectin and moxidectin in nematode-infected lambs.

Lloberas M, Alvarez L, Entrocasso C, Ballent M, Virkel G, Luque S, Lanusse C, Lifschitz A.

N Z Vet J. 2015 Jul;63(4):227-34. doi: 10.1080/00480169.2015.1015645. Epub 2015 May 18.

PMID:
25689407
48.

Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.

Crespo E, Lucia M, Cruzado JM, Luque S, Melilli E, Manonelles A, Lloberas N, Torras J, Grinyó JM, Bestard O.

PLoS One. 2015 Feb 17;10(2):e0117618. doi: 10.1371/journal.pone.0117618. eCollection 2015.

49.

Patient risk factors for developing a drug-related problem in a cardiology ward.

Urbina O, Ferrández O, Luque S, Grau S, Mojal S, Pellicer R, Riu M, Salas E, Comin-Colet J.

Ther Clin Risk Manag. 2014 Dec 17;11:9-15. doi: 10.2147/TCRM.S71749. eCollection 2015.

50.

Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries.

Asensio MJ, Sánchez M, Galván B, Herrero E, Cachafeiro L, Agrifoglio A, Perales E, Luque S, García-de-Lorenzo A.

Intensive Care Med. 2015 Feb;41(2):371-2. doi: 10.1007/s00134-014-3586-z. Epub 2014 Dec 3. No abstract available.

PMID:
25465909

Supplemental Content

Support Center